Works matching AU Kuwako, Tomohito

Results: 9

Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

Published in:

BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5

By:

Taniguchi, Yoshihiko;
Tamiya, Akihiro;
Osuga, Mitsuo;
Harada, Daijiro;
Isa, Shun-ichi;
Nakamura, Keiichi;
Mizumori, Yasuyuki;
Shinohara, Tsutomu;
Yanai, Hidetoshi;
Nakatomi, Katsumi;
Oki, Masahide;
Mori, Masahide;
Kuwako, Tomohito;
Yamazaki, Koji;
Tamura, Atsuhisa;
Ando, Masahiko;
Koh, Yasuhiro

Publication type:

Article

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.

Published in:

2017

By:

Imai, Hisao;
Kuwako, Tomohito;
Kaira, Kyoichi;
Masuda, Tomomi;
Miura, Yosuke;
Seki, Kaori;
Sakurai, Reiko;
Utsugi, Mitsuyoshi;
Shimizu, Kimihiro;
Sunaga, Noriaki;
Tomizawa, Yoshio;
Ishihara, Shinichi;
Ishizuka, Takao;
Mogi, Akira;
Hisada, Takeshi;
Minato, Koichi;
Takise, Atsushi;
Saito, Ryusei;
Yamada, Masanobu

Publication type:

journal article

First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations.

Published in:

2015

By:

Kuwako, Tomohito;
Imai, Hisao;
Masuda, Tomomi;
Miura, Yosuke;
Seki, Kaori;
Yoshino, Reiko;
Kaira, Kyoichi;
Utsugi, Mitsuyoshi;
Shimizu, Kimihiro;
Sunaga, Noriaki;
Tomizawa, Yoshio;
Ishihara, Shinichi;
Ishizuka, Takao;
Mogi, Akira;
Hisada, Takeshi;
Minato, Koichi;
Takise, Atsushi;
Saito, Ryusei;
Yamada, Masanobu

Publication type:

journal article

Probably the Mycobacterium avium Complex around the Staple Line Exacerbated after Radiation Therapy.

Published in:

2022

By:

Ito, Masashi;
Yoshii, Akihiro;
Osaki, Takashi;
Kuwako, Tomohito;
Yamaki, Ei;
Kawashima, Osamu

Publication type:

Case Study

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2016, v. 21, n. 2, p. 240, doi. 10.1007/s10147-015-0883-7

By:

Kaira, Kyoichi;
Sunaga, Noriaki;
Imai, Hisao;
Kamide, Yosuke;
Koga, Yasuhiko;
Ono, Akihiro;
Kuwako, Tomohito;
Masuda, Tomomi;
Hisada, Takeshi;
Ishizuka, Tamotsu;
Yamada, Masanobu

Publication type:

Article

Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

Chemotherapy (0009-3157), 2020, v. 65, n. 1-2, p. 21, doi. 10.1159/000508715

By:

Kotake, Mie;
Kuwako, Tomohito;
Imai, Hisao;
Tomizawa, Yoshio;
Kaira, Kyoichi;
Yoshii, Akihiro;
Ochiai, Mai;
Miura, Yosuke;
Osaki, Takashi;
Sakurai, Reiko;
Takei, Kousuke;
Minato, Koichi;
Saito, Ryusei

Publication type:

Article

Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

Published in:

Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861

By:

Tamiya, Akihiro;
Mizumori, Yasuyuki;
Osuga, Mitsuo;
Isa, Shun‐ichi;
Taniguchi, Yoshihiko;
Nakamura, Keiichi;
Harada, Daijiro;
Shinohara, Tsutomu;
Yanai, Hidetoshi;
Nakatomi, Katsumi;
Oki, Masahide;
Mori, Masahide;
Kuwako, Tomohito;
Yamazaki, Koji;
Tamura, Atsuhisa;
Ando, Masahiko;
Koh, Yasuhiro

Publication type:

Article

Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.

Published in:

Investigational New Drugs, 2025, v. 43, n. 1, p. 101, doi. 10.1007/s10637-024-01500-9

By:

Taniguchi, Yoshihiko;
Tamiya, Akihiro;
Osuga, Mitsuo;
Isa, Shun-ichi;
Nakamura, Keiichi;
Mizumori, Yasuyuki;
Shinohara, Tsutomu;
Yanai, Hidetoshi;
Nakatomi, Katsumi;
Oki, Masahide;
Mori, Masahide;
Kuwako, Tomohito;
Yamazaki, Koji;
Shimada, Masahiro;
Ando, Masahiko;
Koh, Yasuhiro

Publication type:

Article

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.

Published in:

2020

By:

Kasahara, Norimitsu;
Sunaga, Noriaki;
Kuwako, Tomohito;
Naruse, Ichiro;
Imai, Hisao;
Jingu, Asuka;
Tsukagoshi, Yusuke;
Masuda, Tomomi;
Kitahara, Shinsuke;
Tsurumaki, Hiroaki;
Yatomi, Masakiyo;
Hara, Kenichiro;
Koga, Yasuhiko;
Sakurai, Reiko;
Mori, Keita;
Kaira, Kyoichi;
Maeno, Toshitaka;
Asao, Takayuki;
Hisada, Takeshi

Publication type:

journal article